secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENANTA PHARMACEUTICALS INC (ENTA)
CIK:        0001177648
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0000950170-24-029889
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enanta shareholders approve 975,000-share increase to 2019 Equity Incentive Plan
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2019 Equity Incentive Plan, increasing share reserve by 975,000 shares.
- Re-elected Class II directors Yujiro S. Hata, Kristine Peterson, and Terry C. Vance.
- Advisory say-on-pay vote passed with 12,306,697 votes for (79.4% of votes cast).
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1177648/000095017024029889/0000950170-24-029889-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1177648/000095017024029889/enta-20240306.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-029889

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer